Fig. 2From: B-cell imaging with zirconium-89 labelled rituximab PET-CT at baseline is associated with therapeutic response 24 weeks after initiation of rituximab treatment in rheumatoid arthritis patientsExample of a 89Zr-rituximab positron emission tomography (PET) image of the wrists/hands of a patient with rheumatoid arthritis who had multiple PET-positive joints. Red arrow represents one PET-positive joint (green/yellow). SUV standardized uptake valuesBack to article page